Psychiatry and Neurology, Neurology · Austin, TX
NPI
1760445407
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2200 Park Bend Dr, Bldg 2 Ste 203
Austin, TX, 78758
Phone (512) 339-8831
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
1,266 services
Medicare patients, 2024
386
Average age 65
Drug cost, 2024
$4.1M
8,995 prescriptions
Company payments, 2025
$8,382
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sami M Aboumatar was code 99214 (office e&m - established), 299 times for 228 patients. In total Sami M Aboumatar billed 1,266 services in 24 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 299 | 228 | $64.75 | $19K |
| 99215 Office E&M - Established | Office | 291 | 197 | $112.73 | $33K |
| 95720 Neurologic | Facility | 128 | 31 | $145.43 | $19K |
| 95708 Neurologic | Office | 121 | 41 | $105.59 | $13K |
| 95970 Electrical Nerve Conductivity | Office | 70 | 37 | $11.82 | $827 |
| 99232 Hospital E&M - Subsequent | Facility | 69 | 15 | $55.83 | $3,853 |
| 95816 Neurologic | Office | 61 | 59 | $280.14 | $17K |
| 95700 Neurologic | Office | 43 | 41 | $129.69 | $5,577 |
| 95718 Neurologic | Facility | 37 | 26 | $94.12 | $3,483 |
| 95723 Neurologic | Office | 36 | 35 | $168.72 | $6,074 |
| 99205 Office E&M - New | Office | 29 | 29 | $138.66 | $4,021 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $122.55 | $1,961 |
| 95976 Electrical Nerve Conductivity | Office | 16 | 11 | $24.49 | $392 |
By year: 2022 $155K for 1,407 services; 2023 $134K for 1,198 services; 2024 $131K for 1,266 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sami M Aboumatar prescribed most often to Medicare patients was Levetiracetam, with 812 prescriptions and refills. In total Sami M Aboumatar wrote 8,995 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 812 | 1,888 | 207 | $39K |
| Lacosamide Generic | 715 | 1,235 | 132 | $111K |
| Lamotrigine Generic | 561 | 1,293 | 131 | $14K |
| Clobazam Generic | 498 | 730 | 79 | $71K |
| Zonisamide Generic | 448 | 1,066 | 106 | $20K |
| Xcopri Cenobamate | 416 | 464 | 53 | $573K |
| Divalproex Sodium Er Divalproex Sodium | 326 | 669 | 64 | $31K |
| Topiramate Generic | 323 | 653 | 68 | $7,467 |
| Clonazepam Generic | 282 | 411 | 49 | $2,674 |
| Gabapentin Generic | 266 | 558 | 67 | $6,434 |
| Epidiolex Cannabidiol (Cbd) | 257 | 293 | 28 | $837K |
| Briviact Brivaracetam | 229 | 270 | 31 | $421K |
| Escitalopram Oxalate Generic | 189 | 419 | 47 | $2,497 |
| Oxcarbazepine Generic | 179 | 347 | 35 | $22K |
| Trazodone Hcl Generic | 157 | 289 | 38 | $1,212 |
Brand drugs: 1,725 claims; generic drugs: 7,198 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sami M Aboumatar $8,382 ($7,882 in general payments such as food, travel and fees and $500 for research) from 14 companies. The largest payer was SK Life Science, Inc. with $6,910.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 21 | $6,910 |
| Neuropace, Inc. NPCE | 1 | $500 |
| UCB, Inc. UCB.BR | 20 | $319 |
| Otter Pharmaceuticals, LLC | 5 | $162 |
| Pfizer Inc. PFE | 6 | $116 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $99.65 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $56.29 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $51 |
| Neurelis, Inc. | 2 | $42.38 |
| Abbvie Inc. ABBV | 2 | $41.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.